Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
MediPharm Labs Corp. (T.LAB) had Return on Investments of -11.97% for the most recently reported fiscal quarter, ending 2020-09-30.
| Income Statement Financials | |
-- |
|
-11.24M |
|
-- |
|
-- |
|
-- |
|
-12.58M |
|
-- |
|
-11.58M |
|
-11.58M |
|
-11.50M |
|
-11.50M |
|
-11.50M |
|
-11.50M |
|
-12.58M |
|
-11.60M |
|
136.02M |
|
136.02M |
|
-0.08 |
|
-0.08 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
112.81M |
|
-- |
|
-- |
|
-- |
|
34.52M |
|
78.29M |
|
78.29M |
|
78.29M |
|
139.59M |
|
| Cash Flow Statement Financials | |
-22.87M |
|
-5.57M |
|
26.80M |
|
29.01M |
|
27.38M |
|
-1.63M |
|
3.81M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.89 |
|
-- |
|
-- |
|
0.18 |
|
0.30 |
|
-214.03% |
|
-338.53% |
|
-338.53% |
|
-- |
|
-311.74% |
|
-302.45% |
|
-28.43M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
0.49 |
|
0.17 |
|
542.55 |
|
-14.68% |
|
-14.68% |
|
-10.19% |
|
|
Return on Investments |
-11.97% |
0.75 |
|
-0.21 |
|
-0.17 |
|